Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
51.32 USD | -0.55% | +0.95% | +13.38% |
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.38% | 9.97B | B+ | ||
+14.62% | 80.52B | B- | ||
+7.55% | 52.58B | B+ | ||
+1.10% | 48.5B | B | ||
+8.95% | 42.2B | B+ | ||
+6.91% | 40.52B | B+ | ||
+19.13% | 38.2B | B | ||
-8.80% | 27.49B | B- | ||
-19.52% | 25.04B | A- | ||
+6.12% | 22.12B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UNM Stock
- Ratings Unum Group